Farmas USA

Deberiamos poner una norma para el tema de los pre y los after para no sobresaltarnos innecesariamente.
Son muy poco liquidos como para obviar volumen.

pre de AMRN -4,6% con 1.200 acciones

:)

GALE

Galena Biopharma to Present at the 20th Annual NewsMakers in the Biotech Industry Conference

today announced that Mark J. Ahn, Ph.D., President and Chief Executive Officer will present a corporate update at the 20th Annual NewsMakers in the Biotech Industry Conference. The presentation will take place on Friday, September 27, 2013 at 3:00 p.m. ET at the Millennium Broadway Hotel in New York, NY.

Estoy de acuerdo, deberíamos especificar siempre el volumen!!!

-1,79%.....1,80K......6,21 X 6,74...

AMRN

Synta Announces Presentations at the 2013 European Cancer Congress
LEXINGTON, Mass.--(BUSINESS WIRE)--Sep. 12, 2013-- Synta Pharmaceuticals Corp. (NASDAQ: SNTA) today announced scheduled presentations at the 2013 ECCO-ESMO-ESTRO European Cancer Congress in Amsterdam, The Netherlands.

“Ganetespib in combination with docetaxel versus docetaxel alone in second line adenocarcinoma patients with KRAS mutations and elevated LDH levels”

Abstract #: 3416
Date and Time: September 29, 2:00 – 4:30 PM CEST
Presenter: Dean Fennell, M.D., Ph.D., University of Leicester, United Kingdom

Interim results from the on-going GALAXY-1 Phase 2b/3 trial that were previously presented at ASCO 2013 will be reviewed. Additional details on the outcomes of patient subgroups with mutated KRAS and elevated LDH will also be provided.

Synta expects that results from a future analysis of the GALAXY-1 trial will be presented at the 2013 World Conference on Lung Cancer in Sydney, Australia during the week of October 27.

“Antimetastatic activity of ganetespib: Preclinical studies and assessment of progressions due to new lesions in the GALAXY-1 NSCLC trial”

Abstract #: 3517
Date: September 29, 2:00 – 4:30 PM CEST
Presenter: Vojo Vukovic, M.D., Ph.D., Synta Pharmaceuticals

Results demonstrating the anti-angiogenic and anti-metastatic properties of ganetespib in preclinical cancer models will be presented.

SNTA

Edito: ya lo había puesto hace unos días, pero lo recuerdo, porqué la primera cita es este domingo....

No tengo muy claro que me apetezca quedarme dentro a ver esos resultados preliminares.
Segun lo que haga el precio esta semana lo ire pensando ...

SNTA

Yo estoy igual....
Las tengo en +14%, y si subimos durante la semana, igual las largo el viernes...

Un saludo

Por cierto,
¿lo dices por algún motivo lo de que no lo tienes muy claro?
¿Temes malos resultados?

Un saludo